BJU International

Papers
(The H4-Index of BJU International is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Reply to ‘Comment on Bertini et al.: area deprivation and PSA screening disparities’ and ‘Comment on socioeconomic disparities in prostate cancer screening: the impact of the Area Deprivati98
Response to Chen et al.88
Building a research profile during residency71
April's reviewers of the month58
The European Association of Urology talent incubator: bridging competencies for holistic urological care58
Surveillance of non‐muscle ‐invasive bladder cancer with blue‐light cystoscopy: a meta‐analysis57
Acupuncture: a promising adjuvant strategy for pain management among the patients with prostate cancer53
51
April's reviewers of the month49
Efficacy of RestoreX after prostatectomy: open‐label phase of a randomised controlled trial49
Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice?48
Nephrectomy for kidney tumour increases the risk of de novo arterial hypertension47
Vitamin C as an adjunct to methenamine hippurate use after ALTAR: ego or evidence‐based?42
Recent key papers in prostate cancer42
The LANDMARK project: providing summaries of key papers that have shaped urological practice42
Comparison of the effects of extrinsic compression on the drainage performance of three ureteric stents42
Editorial Board40
Active surveillance versus enzalutamide for low‐risk prostate cancer – was it really a trial we needed?39
39
Author Index35
Flexible ureterorenoscopy or extracorporeal shockwave lithotripsy in stone disease and bevacizumab for hereditary and sporadic papillary renal‐cell cancer35
MRI in combination with Technetium‐99m‐sestamibi single‐photon emission CT/CT: a novel diagnostic algorithm to maximise the characterisation of small renal masses33
September's reviewers of the month30
Feasibility and outcomes of interventions to reduce cystoscopy discomfort: a multi‐site pilot study30
MRI , Prostate cancer diagnosis, and Artificial Intelligence; What are the implications?29
Age‐related PSA testing for prostate cancer: NICE recommendation 1.6.329
Eve's and Adam's rib for prostate cancer screening29
Editorial Board27
ChatGPT – Integrity: Artificial Intelligence Misuse in Medical Writing27
0.30541014671326